> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Biotronik Pulsar-18 T3 Stent Approved
- URL: https://www.fdaweb.com/biotronik-pulsar-18-t3-stent-approved/
- Published: 2022-07-26T12:00:00.000Z
- Updated: 2026-09-14T17:53:19.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5152372

FDA has approved a Biotronik PMA for its [Pulsar-18 T3](https://www.biotronik.com/en-us/products/peripheral/pulsar-18T3?ref=fdaweb.com) peripheral self-expanding stent system that is designed to improve implantation procedures for endovascular treatments. The device features a 4-French low-profile delivery system that is intended to decrease the risk of access site complications and reduce the need for closure devices when compared to 6-French devices, the company says. Its tri-axial system with braided shaft design helps to maintain a stable and accurate implantation of the Pulsar stent, which has thin struts and a low chronic outward force that helps to contribute to a reduced mean area of restenosis, it says. The device is indicated for use to improve luminal diameter in patients with symptomatic *de novo*, restenotic or occlusive lesions located in the superficial femoral or proximal popliteal arteries, with reference vessel diameters from 3.0 to 6.0 mm and total lesion lengths up to 190 mm.